Protalix Biotherapeutics Inc (NYSE-A

LX) announced that it has been added to the Russell 3000 and Russell 2000 Indexes, effective after the US market closed on Friday, June 27. The inclusion follows the annual reconstitution of the Russell indexes by global index provider FTSE Russell.